论文部分内容阅读
微生态调节剂的开发与研究受到人们的普遍重视。肝炎后肝硬化患者肠道中的有益菌(双岐杆菌等)减少或消失,大肠杆菌等增加并转为优势菌,导致血内毒素升高。肠道菌群紊乱与肝功能损害程度密切相关。因此,正确使用微生态调节剂可以维护肝硬化患者的肠道微生态平衡,减少内毒素的产生与吸收,对稳定病情起着积极的作用
The development and research of microecological regulator have received universal attention. Beneficial bacteria in the intestine of patients with posthepatitis cirrhosis (such as Bifidobacterium) decreased or disappeared, E. coli and increased to dominant bacteria, leading to elevated blood endotoxin. Intestinal flora and liver damage is closely related to the degree of damage. Therefore, the correct use of micro-ecological regulator can maintain the intestinal microflora balance in patients with cirrhosis and reduce endotoxin production and absorption, plays a positive role in the stability of the disease